Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptic drug levetiracetam

Epilepsia

Volumn 48, Issue 4, 2007, Pages 654-662

  Carunchio, Irene ^a,b   Pieri, Massimo ^a,b   Ciotti, Maria Teresa ^b   Albo, Federica ^a,b   Zona, Cristina ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Cortical neurons; Electrophysiology; Epilepsy; Glutamate receptors; Mouse

Indexed keywords

AMPA RECEPTOR; ANTICONVULSIVE AGENT; ETIRACETAM; KAINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO; EPILEPSY; EXCITATORY POSTSYNAPTIC POTENTIAL; MEMBRANE CONDUCTANCE; MEMBRANE POTENTIAL; MOUSE; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; PATCH CLAMP; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; WHOLE CELL;

ACTION POTENTIALS; ANIMALS; ANTICONVULSANTS; CELLS, CULTURED; CEREBRAL CORTEX; EXCITATORY AMINO ACID AGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; KAINIC ACID; MICE; NEURONS; PATCH-CLAMP TECHNIQUES; PIRACETAM; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID;

EID: 34247145481     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2006.00973.x     Document Type: Article

References (41)

1. Barton ME, Peters SC, Shannon HE. (2003) Comparison of the effect of glutamate receptor modulators in the 6Hz and maximal electroshock seizure models. Epilepsy Research 56:17-26.
2. Burnashev N, Monyer H, Seeburg PH, Sakmann B. (1992) Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 8:189-198.
3. Chapman AG, Meldrum BS. (1989) Non-competitive N-methyl-D-aspartate antagonists protect against sound-induced seizures in DBA/2 mice. European Journal of Pharmacology 166:201-211.
4. Chapman AG, Smith SE, Meldrum BS. (1991) The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice. Epilepsy Research 9:92-96.
5. Chapman AG, Nanan K, Yip P, Meldrum BS. (1999) Anticonvulsant activity of a metabotropic glutamate receptor 8 preferential agonist, (R,S)-4- phosphonophenylglycine. European Journal of Pharmacology 383:23-27.
6. Chapman AG, Nanan K, Williams M, Meldrum BS. (2000) Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893). Neuropharmacology 39:1567-1574.
7. Chung RS, McCormack GH, King AE, West AK, Vickers JC. (2005) Glutamate induces rapid loss of axonal neurofilament proteins from cortical neurons in vitro. Experimental Neurology 193:481-488.
8. Dingledine R, Borges K, Bowie D, Traynelis SF. (1999) The glutamate receptor ion channels. Pharmacology Reviews 51:7-61.
9. Dooley M, Plosker GL. (2000) Levetiracetam. A review of its adjunctive use in the management of partial onset seizures. Drugs 60:871-893.
10. Dugan LL, Bruno VM, Amagasu SM, Giffard RG. (1995) Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity. Journal of Neuroscience 15:4545-4555.
11. During MJ, Spencer DD. (1993) Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 341:1607-1610.
12. Fay MA, Sheth RD, Gidal BE. (2005) Oral absorption kinetics of Levetiracetam: the effect of mixing with food or enteral nutrition formulas. Clinical therapeutics. 27:594-598.
13. Fuks B, Gillard M, Michel P, Lynch B, Vertongen P, Leprince P, Klitgaard H, Chatelain P. (2003) Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell lines. European Journal of Pharmacology 478:11-19.
14. Gasparini F, Bruno V, Battaglia G, Lukic S, Leonhardt T, Inderbitzin W, Laurie D, Sommer B, Varney MA, Hess SD, Johnson EC, Kuhn R, Urwyler S, Sauer D, Portet C, Schmutz M, Nicoletti F, Flor PJ. (1999) (R,S)-4- phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo. The Journal of Pharmacology and Experimental Therapeutics 289:1678-1687.
15. Geiger JR, Melcher T, Koh DS, Sakmann B, Seeburg PH, Jonas P, Monyer H. (1995) Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron 15:193-204.
16. Hans G, Nguyen L, Rocher V, Belachew S, Moonen G, Matagne A, Klitgaard H. (2000) Levetiracetam: no relevant effect on ionotropic excitatory glutamate receptors. Epilepsia 41(suppl 7):35.
17. Hatton CJ, Shelley C, Brydson M, Beeson D, Colquhoun D. (2003) Properties of the human muscle nicotinic receptor, and of the slow-channel myasthenic syndrome mutant epsilon L221F, inferred from maximum likelihood fits. Journal of Physiology 547:729-760.
18. Hollmann M, Heinemann S. (1994) Cloned glutamate receptors. Annual Review of Neuroscience 17:31-108.
19. Levi G, Gallo V, Ciotti MT. (1986) Bipotential precursors of putative fibrous astrocytes and oligodendrocytes in rat cerebellar cultures express distinct surface features and "neuron-like" gamma-aminobutyric acid transport. Proceedings of the National Academy of Sciences of the United States of America 83:1504-1508.
20. Loscher W, Honack D. (1994) Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil. British Journal of Pharmacology 113:1349-1357.
21. Lukyanetz EA, Shkryl VM, Kostyuk PG. (2002) Selective blockade of N-type calcium channels by levetiracetam. Epilepsia 43:9-18.
22. Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B. (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proceedings of the National Academy of Sciences of the United States of America 101:9861-9866.
23. McBain CJ, Mayer ML. (1994) N-methyl-D-aspartic acid receptor structure and function. Physiology Reviews 74:723-760.
24. Margineanu D, Klitgaard H. (2002) Levetiracetam: mechanism of action. In Levy R, Mattson R, Meldrum B, EP (Eds) Antiepileptic drugs. Lippincott, Williams & Wilkins, Philadelphia, pp. 419-427.
25. Margineanu DG, Klitgaard H. (2003) Levetiracetam has no significant gamma-aminobutyric acid-related effect on paired-pulse interaction in the dentate gyrus of rats. European Journal of Pharmacology 466:255-261.
26. Mathern GW, Pretorius JK, Kornblum HI, Mendoza D, Lozada A, Leite JP, Chimelli L, Born DE, Fried I, Sakamoto AC, Assirati JA, Peacock WJ, Ojemann GA, Adelson PD. (1998) Altered hippocampal kainate-receptor mRNA levels in temporal lobe epilepsy patients. Neurobiology of Disease 5:151-176.
27. Mathern GW, Pretorius JK, Mendoza D, Leite JP, Chimelli L, Born DE, Fried I, Assirati JA, Ojemann GA, Adelson PD, Cahan LD, Kornblum HI. (1999) Hippocampal N-methyl-D-aspartate receptor subunit mRNA levels in temporal lobe epilepsy patients. Annals of Neurology 46:343-358.
28. Meldrum BS, Akbar MT, Chapman AG. (1999) Glutamate receptors and transporters in genetic and acquired models of epilepsy. Epilepsy Research 36:189-204.
29. Notenboom RG, Hampson DR, Jansen GH, van Rijen PC, van Veelen CW, van Nieuwenhuizen O, de Graan PN. (2006) Up-regulation of hippocampal metabotropic glutamate receptor 5 in temporal lobe epilepsy patients. Brain 129:96-107.
30. Ozawa S, Kamiya H, Tsuzuki K. (1998) Glutamate receptors in the mammalian central nervous system. Progress in Neurobiology 54:581-618
31. Palmer GC, Harris EW, Ray R, Stagnitto ML, Schmiesing RJ. (1992) Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro. Archives Internationales de Pharmacodynamie et de Thérapie 317:16-34.
32. Pieri M, Severini C, Amadoro G, Carunchio I, Barbato C, Ciotti MT, Zona C. (2005) AMPA receptors are modulated by tachykinins in rat cerebellum neurons. Journal of Neurophysiology 94:2484-2490.
33. Rambeck B, Jürgens UH, May TW, Pannek HW, Behne F, Ebner A, Gorji A, Straub H, Speckmann EJ, Pohlmann-Eden B, Löscher W. (2006) Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy. Epilepsia 47:681-694.
34. Rigo JM, Hans G, Nguyen L, Rocher V, Belachew S, Malgrange B, Leprince P, Moonen G, Selak I, Matagne A, Klitgaard H. (2002) The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. British Journal of Pharmacology 136:659-672.
35. Stefan H, Wang-Tilz Y, Pauli E, Dennhöfer S, Genow A, Kerling F, Lorber B, Fraunberger B, Halboni P, Koebnick C, Gefeller O, Tilz C. (2006) Onset of action of Levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA). Epilepsia 47:616-522
36. Steinschneider R, Delmas P, Nedelec J, Gola M, Bernard D, Boucraut J. (1996) Appearance of neurofilament subunit epitopes correlates with electrophysiological maturation in cortical embryonic neurons cocultured with mature astrocytes. Brain Research. Developmental Brain Research 95: 15-27
37. Storm-Mathisen J, Ottersen OP. (1989) Anatomy of putative glutamatergic neurons. In Avoli M, Reader TA, Dykes RW, Gloor P (Eds) Neurotransmitters and cortical function. Plenum Press, London, pp. 39-70.
38. Tricklebank MD, Singh L, Oles RJ, Preston C, Iversen SD. (1989) The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. European Journal of Pharmacology 167:127-135.
39. Vorobjev VS, Sharonova IN, Haas HL, Sergeeva OA. (2000) Differential modulation of AMPA receptors by cyclothiazide in two types of striatal neurons. European Journal of Neuroscience 12:2871-2880.
40. Yamaguchi S, Donevan SD, Rogawski MA. (1993) Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models. Epilepsy Research 15:179-184.
41. Zona C, Niespodziany I, Marchetti C, Klitgaard H, Bernardi G, Margineanu DG. (2001) Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents. Seizure 10:279-286.